CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Tranexamic Acid

氨甲环酸 杂质对照品Tranexamic Acid Impurities

EP62 个杂质条目62 impurity entries

本页汇总 氨甲环酸 的 62 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 62 impurity reference standards of Tranexamic Acid with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 氨甲环酸(Tranexamic Acid)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of an assay to quantify tranexamic acid levels in plasma
    Analytical biochemistry · 2025 · Kim PY et al.  ·  PMID 39521358  ·  DOI
  2. 杂质研究Impurity studiesTranexamic Acid-Associated Hyaluronic Acid Exhibits Enhanced Oxidative Stability: A Comparative Rheological Study
    Biomolecules · 2026 · Conrozier T et al.  ·  PMID 41897297  ·  DOI
  3. 杂质研究Impurity studiesStability analysis of tranexamic acid in the presence of various antiseptic solutions
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023 · Heckmann ND et al.  ·  PMID 35730424  ·  DOI
  4. 分析方法Analytical MethodsAcetonitrile Adducts of Tranexamic Acid as Sensitive Ions for Quantification at Residue Levels in Human Plasma by UHPLC-MS/MS
    Pharmaceuticals (Basel, Switzerland) · 2021 · Silva EMP et al.  ·  PMID 34959606  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisEffect of tranexamic acid (Cyklokapron) on the synthesis of chondroitin sulphate and the content of hexosamine in the same fraction on normal and degenerated joint cartilage in the rabbit
    Acta orthopaedica Scandinavica · 1973 · Telhag H  ·  PMID 4768789  ·  DOI

氨甲环酸 —— 原料药与杂质对照品Tranexamic Acid — drug substance & impurities

共 63 个条目(含原料药本体)63 items incl. the drug substance
Tranexamic Acid structure
EP原料药 APIAPI
氨甲环酸Tranexamic Acid
Tranexamic Acid
CAS No.1197-18-8
Chemical FormulaC8H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 1 (Tranexamic Acid EP Impurity A) structure
EPA
氨甲环酸杂质1 (氨甲环酸EP杂质A)Tranexamic Acid Impurity 1 (Tranexamic Acid EP Impurity A)
Tranexamic Acid Impurity 1 (Tranexamic Acid EP Impurity A)
CAS No.93940-19-3
Chemical FormulaC16H27NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 2 (Tranexamic Acid EP Impurity B) structure
EPB
氨甲环酸杂质2 (氨甲环酸EP杂质B)Tranexamic Acid Impurity 2 (Tranexamic Acid EP Impurity B)
Tranexamic Acid Impurity 2 (Tranexamic Acid EP Impurity B)
CAS No.1197-17-7
Chemical FormulaC8H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 3 (Tranexamic Acid EP Impurity C Hydrochloride) structure
EPC
氨甲环酸杂质3 (氨甲环酸EP杂质C 盐酸盐)Tranexamic Acid Impurity 3 (Tranexamic Acid EP Impurity C Hydrochloride)
Tranexamic Acid Impurity 3 (Tranexamic Acid EP Impurity C Hydrochloride)
CAS No.1803601-44-6
Chemical FormulaC8H13NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 3(Tranexamic Acid EP Impurity C Monomer) structure
EPC
氨甲环酸杂质3 (氨甲环酸EP杂质C)Tranexamic Acid Impurity 3(Tranexamic Acid EP Impurity C Monomer)
Tranexamic Acid Impurity 3(Tranexamic Acid EP Impurity C Monomer)
CAS No.330838-52-3
Chemical FormulaC8H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 4 (Tranexamic Acid EP Impurity D) structure
EPD
氨甲环酸杂质4 (氨甲环酸EP杂质D)Tranexamic Acid Impurity 4 (Tranexamic Acid EP Impurity D)
Tranexamic Acid Impurity 4 (Tranexamic Acid EP Impurity D)
CAS No.56-91-7
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 6 Hydrochloride (Tranexamic Acid EP Impurity E Hydrochloride) structure
EPE
氨甲环酸杂质6 盐酸盐 (氨甲环酸EP杂质E 盐酸盐)Tranexamic Acid Impurity 6 Hydrochloride (Tranexamic Acid EP Impurity E Hydrochloride)
Tranexamic Acid Impurity 6 Hydrochloride (Tranexamic Acid EP Impurity E Hydrochloride)
CAS No.157605-44-2
Chemical FormulaC16H28N2O3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 6 (Tranexamic Acid EP Impurity E) structure
EPE
氨甲环酸杂质6 (氨甲环酸EP杂质E)Tranexamic Acid Impurity 6 (Tranexamic Acid EP Impurity E)
Tranexamic Acid Impurity 6 (Tranexamic Acid EP Impurity E)
CAS No.82755-59-7
Chemical FormulaC16H28N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 14 (Tranexamic Acid EP Impurity F) structure
EPF
氨甲环酸杂质14 (氨甲环酸EP杂质F)Tranexamic Acid Impurity 14 (Tranexamic Acid EP Impurity F)
Tranexamic Acid Impurity 14 (Tranexamic Acid EP Impurity F)
CAS No.1599413-49-6
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 2-13C2(Tranexamic Acid EP Impurity B-13C2) structure
EPB-13C2
氨甲环酸杂质2-13C2(氨甲环酸EP杂质B-13C2)Tranexamic Acid Impurity 2-13C2(Tranexamic Acid EP Impurity B-13C2)
Tranexamic Acid Impurity 2-13C2(Tranexamic Acid EP Impurity B-13C2)
CAS No.1557000-06-2
Chemical FormulaC613C2H1515NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 8 structure
8
氨甲环酸杂质8Tranexamic Acid Impurity 8
Tranexamic Acid Impurity 8
CAS No.1642-81-5
Chemical FormulaC8H7ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 9 structure
9
氨甲环酸杂质9Tranexamic Acid Impurity 9
Tranexamic Acid Impurity 9
CAS No.40525-78-8
Chemical FormulaC6H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 10 structure
10
氨甲环酸杂质10Tranexamic Acid Impurity 10
Tranexamic Acid Impurity 10
CAS No.2179-45-5
Chemical FormulaC8H4Cl3N
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 11 structure
11
氨甲环酸杂质11Tranexamic Acid Impurity 11
Tranexamic Acid Impurity 11
CAS No.74231-65-5
Chemical FormulaC8H5Cl2N
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 13 structure
13
氨甲环酸杂质13Tranexamic Acid Impurity 13
Tranexamic Acid Impurity 13
CAS No.874-89-5
Chemical FormulaC8H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 15 structure
15
氨甲环酸杂质15Tranexamic Acid Impurity 15
Tranexamic Acid Impurity 15
CAS No.5278-91-1
Chemical FormulaC8H6Cl2O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 16 structure
16
氨甲环酸杂质16Tranexamic Acid Impurity 16
Tranexamic Acid Impurity 16
CAS No.195370-52-6
Chemical FormulaC8H7Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 17 structure
17
氨甲环酸杂质17Tranexamic Acid Impurity 17
Tranexamic Acid Impurity 17
CAS No.1201-90-7
Chemical FormulaC10H11ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 18 structure
18
氨甲环酸杂质18Tranexamic Acid Impurity 18
Tranexamic Acid Impurity 18
CAS No.10473-24-2
Chemical FormulaC10H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 19 structure
19
氨甲环酸杂质19Tranexamic Acid Impurity 19
Tranexamic Acid Impurity 19
CAS No.20704-66-9
Chemical FormulaC10H17NO3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 20 structure
20
氨甲环酸杂质20Tranexamic Acid Impurity 20
Tranexamic Acid Impurity 20
CAS No.5264-40-4
Chemical FormulaC8H5Cl3O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 21 structure
21
氨甲环酸杂质21Tranexamic Acid Impurity 21
Tranexamic Acid Impurity 21
CAS No.1564748-46-4
Chemical FormulaC8H6Cl2O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 22 structure
22
氨甲环酸杂质22Tranexamic Acid Impurity 22
Tranexamic Acid Impurity 22
CAS No.1306130-66-4
Chemical FormulaC16H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 23 structure
23
氨甲环酸杂质23Tranexamic Acid Impurity 23
Tranexamic Acid Impurity 23
CAS No.27514-08-5
Chemical FormulaC8H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 24 structure
24
氨甲环酸杂质24Tranexamic Acid Impurity 24
Tranexamic Acid Impurity 24
CAS No.104-47-2
Chemical FormulaC9H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 26 structure
26
氨甲环酸杂质26Tranexamic Acid Impurity 26
Tranexamic Acid Impurity 26
CAS No.847416-70-0
Chemical FormulaC13H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 27 structure
27
氨甲环酸杂质27Tranexamic Acid Impurity 27
Tranexamic Acid Impurity 27
CAS No.162046-58-4
Chemical FormulaC13H23NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 28 structure
28
氨甲环酸杂质28Tranexamic Acid Impurity 28
Tranexamic Acid Impurity 28
CAS No.1609407-74-0
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 29 structure
29
氨甲环酸杂质29Tranexamic Acid Impurity 29
Tranexamic Acid Impurity 29
CAS No.167690-53-1
Chemical FormulaC23H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 30 structure
30
氨甲环酸杂质30Tranexamic Acid Impurity 30
Tranexamic Acid Impurity 30
CAS No.173690-50-1
Chemical FormulaC24H27NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 31 structure
31
氨甲环酸杂质31Tranexamic Acid Impurity 31
Tranexamic Acid Impurity 31
CAS No.165947-29-5
Chemical FormulaC14H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 32 structure
32
氨甲环酸杂质32Tranexamic Acid Impurity 32
Tranexamic Acid Impurity 32
CAS No.528894-38-4
Chemical FormulaC23H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 33 structure
33
氨甲环酸杂质33Tranexamic Acid Impurity 33
Tranexamic Acid Impurity 33
CAS No.188715-40-4
Chemical FormulaC23H25NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 34 structure
34
氨甲环酸杂质34Tranexamic Acid Impurity 34
Tranexamic Acid Impurity 34
CAS No.369-53-9
Chemical FormulaC8H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 35 structure
35
氨甲环酸杂质35Tranexamic Acid Impurity 35
Tranexamic Acid Impurity 35
CAS No.84545-14-2
Chemical FormulaC8H8ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 36 structure
36
氨甲环酸杂质36Tranexamic Acid Impurity 36
Tranexamic Acid Impurity 36
CAS No.861518-79-8
Chemical FormulaC16H13ClO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 41 (Arecoline Hydrobromide) structure
41
氨甲环酸杂质41 (氢溴酸槟榔碱)Tranexamic Acid Impurity 41 (Arecoline Hydrobromide)
Tranexamic Acid Impurity 41 (Arecoline Hydrobromide)
CAS No.300-08-3
Chemical FormulaC8H13NO2·HBr
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 42 structure
42
氨甲环酸杂质42Tranexamic Acid Impurity 42
Tranexamic Acid Impurity 42
CAS No.61367-07-5
Chemical FormulaC8H15NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 43 structure
43
氨甲环酸杂质43Tranexamic Acid Impurity 43
Tranexamic Acid Impurity 43
CAS No.2375016-71-8
Chemical FormulaC8H13ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 44 structure
44
氨甲环酸杂质44Tranexamic Acid Impurity 44
Tranexamic Acid Impurity 44
CAS No.19878-18-3
Chemical FormulaC10H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 50 Hydrochloride structure
50
氨甲环酸杂质50 盐酸盐Tranexamic Acid Impurity 50 Hydrochloride
Tranexamic Acid Impurity 50 Hydrochloride
CAS No.29275-88-5
Chemical FormulaC9H17NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 50 structure
50
氨甲环酸杂质50Tranexamic Acid Impurity 50
Tranexamic Acid Impurity 50
CAS No.50738-63-1
Chemical FormulaC9H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 51 structure
51
氨甲环酸杂质51Tranexamic Acid Impurity 51
Tranexamic Acid Impurity 51
CAS No.23199-14-6
Chemical FormulaC9H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 52 structure
52
氨甲环酸杂质52Tranexamic Acid Impurity 52
Tranexamic Acid Impurity 52
CAS No.701-54-2
Chemical FormulaC8H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 55 structure
55
氨甲环酸杂质55Tranexamic Acid Impurity 55
Tranexamic Acid Impurity 55
CAS No.874-86-2
Chemical FormulaC8H6ClN
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 57 structure
57
氨甲环酸杂质57Tranexamic Acid Impurity 57
Tranexamic Acid Impurity 57
CAS No.5592-68-7
Chemical FormulaC8H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 58 structure
58
氨甲环酸杂质58Tranexamic Acid Impurity 58
Tranexamic Acid Impurity 58
CAS No.6294-84-4
Chemical FormulaC8H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 59 structure
59
氨甲环酸杂质59Tranexamic Acid Impurity 59
Tranexamic Acid Impurity 59
CAS No.53919-19-0
Chemical FormulaC8H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 61 structure
61
氨甲环酸杂质61Tranexamic Acid Impurity 61
Tranexamic Acid Impurity 61
CAS No.18524-12-4
Chemical FormulaC6H10O5
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 63 structure
63
氨甲环酸杂质63Tranexamic Acid Impurity 63
Tranexamic Acid Impurity 63
CAS No.13064-83-0
Chemical FormulaC8H14O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 64 structure
64
氨甲环酸杂质64Tranexamic Acid Impurity 64
Tranexamic Acid Impurity 64
CAS No.934-67-8
Chemical FormulaC8H14O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 65 (Mixture of Enantiomers) structure
65
氨甲环酸杂质65 (对映异构体混合物)Tranexamic Acid Impurity 65 (Mixture of Enantiomers)
Tranexamic Acid Impurity 65 (Mixture of Enantiomers)
CAS No.736136-45-1
Chemical FormulaC15H17ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 70 structure
70
氨甲环酸杂质70Tranexamic Acid Impurity 70
Tranexamic Acid Impurity 70
CAS No.1240529-10-5
Chemical FormulaC7H11F2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 75 (Guvacoline) structure
75
氨甲环酸杂质75 (去甲基槟榔碱)Tranexamic Acid Impurity 75 (Guvacoline)
Tranexamic Acid Impurity 75 (Guvacoline)
CAS No.495-19-2
Chemical FormulaC7H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 76 (N-Nitroso Guvacoline) structure
76
氨甲环酸杂质76 (N-亚硝基去甲基槟榔碱)Tranexamic Acid Impurity 76 (N-Nitroso Guvacoline)
Tranexamic Acid Impurity 76 (N-Nitroso Guvacoline)
CAS No.55557-02-3
Chemical FormulaC7H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 77 (Guvacine) structure
77
氨甲环酸杂质77 (四氢烟酸)Tranexamic Acid Impurity 77 (Guvacine)
Tranexamic Acid Impurity 77 (Guvacine)
CAS No.498-96-4
Chemical FormulaC6H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 78 (N-Nitroso Guvacine) structure
78
氨甲环酸杂质78 (N-亚硝基四氢烟酸)Tranexamic Acid Impurity 78 (N-Nitroso Guvacine)
Tranexamic Acid Impurity 78 (N-Nitroso Guvacine)
CAS No.55557-01-2
Chemical FormulaC6H8N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 85 structure
85
氨甲环酸杂质85Tranexamic Acid Impurity 85
Tranexamic Acid Impurity 85
CAS No.2248291-56-5
Chemical FormulaC11H21NO2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 86 structure
86
氨甲环酸杂质86Tranexamic Acid Impurity 86
Tranexamic Acid Impurity 86
CAS No.4331-54-8
Chemical FormulaC8H14O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 88 structure
88
氨甲环酸杂质88Tranexamic Acid Impurity 88
Tranexamic Acid Impurity 88
CAS No.5333-31-3
Chemical FormulaC8H12O2
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 90 structure
90
氨甲环酸杂质90Tranexamic Acid Impurity 90
Tranexamic Acid Impurity 90
CAS No.2469781-80-2
Chemical FormulaC16H27NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 27-13C2 structure
27-13C2
氨甲环酸杂质27-13C2Tranexamic Acid Impurity 27-13C2
Tranexamic Acid Impurity 27-13C2
CAS No.1346604-84-9
Chemical FormulaC1113C2H2315NO4
Purity>95%询价On request
10mg25mg50mg100mg
Tranexamic Acid Impurity 28-13C2 structure
28-13C2
氨甲环酸杂质28-13C2Tranexamic Acid Impurity 28-13C2
Tranexamic Acid Impurity 28-13C2
CAS No.1346600-88-1
Chemical FormulaC1213C2H2515NO4
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

氨甲环酸 —— 研究文献与合成路线Tranexamic Acid — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 氨甲环酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Tranexamic Acid. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation
    Diebel ME, Martin JV, Liberati DM, et al. · The journal of trauma and acute care surgery · 2018 · 被引 40cited 40
  2. Bacteriosynthetic Degradable Tranexamic Acid-Functionalized Short Fibers for Inhibiting Invisible Hemorrhage
    Bao L, Zhang Z, Li X, et al. · Small (Weinheim an der Bergstrasse, Germany) · 2023 · 被引 16cited 16
  3. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage
    Fodstad H, Pilbrant A, Schannong M, et al. · Acta neurochirurgica · 1981 · 被引 23cited 23
  4. Degradation of Glu- and Lys-plasminogen by elastase in the presence or absence of tranexamic acid
    Takada A, Sugawara Y, Takada Y · Thrombosis research · 1988 · 被引 8cited 8
  5. Comparison of the effect of tranexamic acid at various concentrations on the degradation time of platelet-rich fibrin
    Dechtham E, Aschaitrakool Y · The British journal of oral & maxillofacial surgery · 2021 · 被引 1cited 1
  6. Spectrophotometric and spectrofluorimetric methods for the determination of tranexamic acid in pharmaceutical formulation
    El-Aroud KA, Abushoffa AM, Abdellatef HE · Chemical & pharmaceutical bulletin · 2007 · 被引 11cited 11

合成与制备工艺专利Synthesis & process patents

  1. ACYLOXYALKYL CARBAMATE PRODRUGS OF TRANEXAMIC ACID, METHODS OF SYNTHESIS AND USE
    ZERANGUE NOA, JANDELEIT BERND, LI YUNXIAO, GALLOP MARK A · 公开号 US2011009483US2011009483 · 2011
  2. SOLID PREPARATION COMPRISING IBUPROFEN AND TRANEXAMIC ACID
    KANO YUICHIRO, USUI TOSHIKI · 公开号 KR20090065513KR20090065513 · 2009
  3. Solid preparation containing ibuprofen and tranexamic acid
    TOSHIKI ASAI, SHIMOKAWA TATSUHARU, KAWASHIMA HIROYUKI · 公开号 CN101352428CN101352428 · 2009
  4. SOLID PREPARATION CONTAINING IBUPROFEN AND TRANEXAMIC ACID
    USUI TOSHIKI, SHIMOKAWA TATSUHARU, KAWASHIMA HIROYUKI · 公开号 JP2009203218JP2009203218 · 2009
  5. Acyloxyalkyl Carbamate Prodrugs of Tranexamic Acid, Methods of Synthesis and Use
    ZERANGUE NOA, JANDELEIT BERND, LI YUNXIAO, GALLOP MARK A · 公开号 US2010036148US2010036148 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

氨甲环酸 杂质谱研究要点Tranexamic Acid — impurity profiling notes

下面这些是拿到 氨甲环酸 的 63 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 63 impurity entries for Tranexamic Acid, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances